Monday, March 12, 2007


There's a new cancer development that is in clinical trials.  It was developed by Dr. Stanislaw Burzynski and uses antineoplastons which is a naturally occurring substance that alters the genetics of the cancer cells.

Preliminary results from six brain tumor studies gave a combined overall response rate of from 68% to 88%.  For information, call the Burzynski Clinic in Houston at (281) 597-0111

No comments: